Marsh (MRSH) Q1 2026 (USD): Adj. EPS 3.29 (exp. 3.23), Revenue 7.6bln (exp. 7.41bln)

Marsh's Q1 2026 results outpaced expectations for both adjusted EPS and revenue, signaling stronger-than-anticipated operational performance.

Newsquawk StaffPublished On the live feed at 5 more headlines followed before this page went public
Newsquawk headlinesUTC

U.S. Bancorp (USB) Q1 2026 (USD): Adj. EPS 1.18 (exp. 1.15), Revenue 7.29bln (exp. 7.28bln), guides Q2 revenue +4-6% Y/Y and NII +6-7% Y/Y

ACHIEVE-4, the longest Phase 3 study of Eli Lilly's (LLY) Foundayo (orforglipron) to date, reaffirmed its cardiovascular and overall safety profile as well as consistent improvements across key measures of cardiometabolic health

Marsh (MRSH) Q1 2026 (USD): Adj. EPS 3.29 (exp. 3.23), Revenue 7.6bln (exp. 7.41bln)

Intertek (ITRK LN) rejects indicative cash proposal from EQT on April 10 and is mulling options

Bank of New York Mellon Corp (BK) Q1 2026 (USD) EPS 2.25 (exp. 1.93), Revenue 5.41bln (exp. 5.17bln), announces a USD 10bln share buyback

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

This beat may reflect positively on investor sentiment towards Marsh and could generate upward momentum in the stock, while also providing a favorable outlook for peers in the sector.

Related headlines

The whole workspace, free to try.

Try it free